CIPLA
|
The Current P/B Ratio of CIPLA is 3.28.
| Share Price | ₹1,397.2 | Sep 25,2026 |
| Market Cap | ₹112,879.8 Cr | |
| Book Value | ₹34,369.4 Cr | Mar2026 - Consolidated Results |
| Price/Book | 3.28x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of CIPLA
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹112,879.8 Cr] as on Sep 25,2026
(/) Book Value [ ₹34,369.4 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 3.28x ]
Thus, for CIPLA , the investors are currently willing to pay '3.28 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CIPLA !
The chart below summarizes the trend in P/B Ratio of CIPLA over the last five years.
Historical PB (Price/Book ) ratio chart of CIPLA
PB Ratio Performance Analysis for CIPLA
- CIPLA 's p/b ratio for fiscal years ending Mar2026 to Mar2022 averaged 3.64x.
- CIPLA 's operated at median p/b ratio of 3.75x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CIPLA 's p/b ratio peaked in Mar2024 at 4.53x.
- CIPLA 's p/b ratio hit its five-year low in Mar2026 of 2.87x.
How does CIPLA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| CIPLA | 34,369.40 | 3.28 | 112,879.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.32 | 444,717.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 15.22 | 255,115.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 22.60 | 189,613.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.66 | 100,395.0 |
| MANKIND PHARMA LTD | 16,252.60 | 6.29 | 102,247.0 |
| LUPIN LTD | 22,384.10 | 4.27 | 95,573.6 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.42 | 119,900.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.60 | 98,464.4 |
| LAURUS LABS LTD | 5,275.08 | 20.50 | 108,116.0 |
| BIOCON LTD | 33,517.50 | 1.85 | 62,091.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CIPLA 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 1.85x |
| Max industry PB | 22.60x |
| Median industry PB | 4.42x |
| Average industry PB | 8.09x |
You may also like the below Video Courses